Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Glycobiology"
DOI: 10.1093/glycob/cwy108
Abstract: The hepatitis B virus (HBV)-induced chronic liver diseases are serious health threats worldwide. There is evidence to display the alterations of salivary N-linked glycans related to the development of HBV-infected liver diseases. Here, we further… read more here.
Keywords: hcc; glycans recognized; recognized ltl; hbv induced ... See more keywords
Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1147379
Abstract: Background Liver fibrosis is a reversible wound-healing response that can lead to end-stage liver diseases without effective treatment, in which HBV infection is a major cause. However, the underlying mechanisms for the development of HBV-induced… read more here.
Keywords: egcg; hbv induced; induced liver; hmgb1 ... See more keywords
The Origin of Capsid-Derived Immune Complexes and Their Impact on HBV-Induced Liver Diseases
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14122766
Abstract: Over 240 million people worldwide are chronically infected with Hepatitis B Virus (HBV), a hepatotropic DNA virus with an evolutionary root of over 400 million years. Persistent HBV infection exhibits distinct and diverse phases of… read more here.
Keywords: derived immune; hbv; hbv induced; capsid derived ... See more keywords